Annual ROE
49.91%
-10.91%-17.94%
31 December 2023
Summary:
Cartesian Therapeutics annual return on equity is currently 49.91%, with the most recent change of -10.91% (-17.94%) on 31 December 2023. During the last 3 years, it has risen by +1187.76% (+104.39%). RNAC annual ROE is now -86.95% below its all-time high of 382.52%, reached on 01 December 2020.RNAC ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROE
148.90%
-4.68%-3.05%
01 September 2024
Summary:
Cartesian Therapeutics quarterly return on equity is currently 148.90%, with the most recent change of -4.68% (-3.05%) on 01 September 2024. Over the past year, it has increased by +196.59% (+412.22%). RNAC quarterly ROE is now -90.33% below its all-time high of 1540.02%, reached on 01 June 2020.RNAC Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RNAC ROE Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -17.9% | +412.2% |
| 3 y3 years | +104.4% | -71.0% |
| 5 y5 years | +101.3% | +107.0% |
RNAC ROE High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -87.0% | +104.4% | -71.0% | +412.2% |
| 5 y | 5 years | -87.0% | +101.3% | -90.3% | +104.5% |
| alltime | all time | -87.0% | +101.3% | -90.3% | +104.5% |
Cartesian Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | 148.90%(-3.0%) |
| June 2024 | - | 153.58%(-35.0%) |
| Mar 2024 | - | 236.43%(-35.5%) |
| Dec 2023 | 49.91%(-17.9%) | 366.45%(-868.4%) |
| Sept 2023 | - | -47.69%(+11.1%) |
| June 2023 | - | -42.91%(+127.2%) |
| Mar 2023 | - | -18.89%(-137.0%) |
| Dec 2022 | 60.82%(-105.3%) | - |
| Dec 2022 | - | 51.03%(-42.7%) |
| Sept 2022 | - | 89.13%(-18.6%) |
| June 2022 | - | 109.44%(-71.7%) |
| Mar 2022 | - | 387.13%(-24.6%) |
| Dec 2021 | -1137.85%(-397.5%) | 513.66%(+45.6%) |
| Sept 2021 | - | 352.70%(-4.1%) |
| June 2021 | - | 367.68%(-27.8%) |
| Mar 2021 | - | 509.23%(-12.8%) |
| Dec 2020 | 382.52% | 583.66%(-55.6%) |
| Sept 2020 | - | 1313.81%(-14.7%) |
| June 2020 | - | 1540.02%(-147.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | -3277.88%(+53.3%) |
| Dec 2019 | -3716.01%(+1219.4%) | -2138.88%(+12.9%) |
| Sept 2019 | - | -1894.96%(+180.3%) |
| June 2019 | - | -676.14%(+87.4%) |
| Mar 2019 | - | -360.85%(+35.0%) |
| Dec 2018 | -281.65%(+130.2%) | -267.24%(+46.7%) |
| Sept 2018 | - | -182.19%(+38.0%) |
| June 2018 | - | -132.04%(+11.0%) |
| Mar 2018 | - | -118.95%(+6.0%) |
| Dec 2017 | -122.36%(+85.7%) | -112.19%(+14.2%) |
| Sept 2017 | - | -98.21%(+14.5%) |
| June 2017 | - | -85.77%(-4.3%) |
| Mar 2017 | - | -89.67%(-56.9%) |
| Dec 2016 | -65.89%(-404.9%) | -208.04%(-42.4%) |
| Sept 2016 | - | -361.43%(-249.1%) |
| June 2016 | - | 242.45%(+360.1%) |
| Mar 2016 | - | 52.70%(+143.9%) |
| Dec 2015 | 21.61%(+47.2%) | 21.61% |
| Dec 2014 | 14.68% | - |
FAQ
- What is Cartesian Therapeutics annual return on equity?
- What is the all time high annual ROE for Cartesian Therapeutics?
- What is Cartesian Therapeutics annual ROE year-on-year change?
- What is Cartesian Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Cartesian Therapeutics?
- What is Cartesian Therapeutics quarterly ROE year-on-year change?
What is Cartesian Therapeutics annual return on equity?
The current annual ROE of RNAC is 49.91%
What is the all time high annual ROE for Cartesian Therapeutics?
Cartesian Therapeutics all-time high annual return on equity is 382.52%
What is Cartesian Therapeutics annual ROE year-on-year change?
Over the past year, RNAC annual return on equity has changed by -10.91% (-17.94%)
What is Cartesian Therapeutics quarterly return on equity?
The current quarterly ROE of RNAC is 148.90%
What is the all time high quarterly ROE for Cartesian Therapeutics?
Cartesian Therapeutics all-time high quarterly return on equity is 1540.02%
What is Cartesian Therapeutics quarterly ROE year-on-year change?
Over the past year, RNAC quarterly return on equity has changed by +196.59% (+412.22%)